China’s sheer size, ageing population, growing middle class and rapid economic development have all encouraged fantastic predictions about the potential of its healthcare and pharmaceutical markets. PricewaterhouseCoopers has forecast that China will become the world’s fifth biggest pharmaceutical market by 2010 and overtake the US as the top pharmaceutical market by 2050. Official statistics suggest total revenues of China’s pharmaceutical industry in 2006 were around US$64 billion, up...
Sorry, you do not have access to this page because you are not logged in.
If you are not a subscriber or a trialist and you want to discuss how to access our work please:
Trusted Sources helps clients identify investment opportunities in emerging markets, exploit them with greater confidence and stay alert to associated risks.
Learn more about our approach, our team and our research, as well as our media appearances.
